Craig Hallum initiated coverage on shares of Astera Labs (NASDAQ:ALAB – Free Report) in a research report sent to investors on Monday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $90.00 price objective on the stock.
ALAB has been the topic of several other research reports. JPMorgan Chase & Co. started coverage on shares of Astera Labs in a report on Monday. They issued an overweight rating and a $85.00 target price on the stock. Needham & Company LLC initiated coverage on shares of Astera Labs in a report on Monday. They set a buy rating and a $85.00 price objective on the stock. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Astera Labs in a report on Monday. They set a buy rating and a $85.00 price objective on the stock. Barclays initiated coverage on shares of Astera Labs in a report on Monday. They set an overweight rating and a $85.00 price objective on the stock. Finally, Jefferies Financial Group initiated coverage on shares of Astera Labs in a report on Monday. They set a buy rating and a $85.00 price objective on the stock. Eleven investment analysts have rated the stock with a buy rating, According to MarketBeat, Astera Labs currently has an average rating of Buy and an average target price of $86.09.
Read Our Latest Report on ALAB
Astera Labs Trading Down 3.1 %
Insider Buying and Selling at Astera Labs
In other Astera Labs news, Director Jack R. Lazar purchased 10,000 shares of Astera Labs stock in a transaction on Friday, March 22nd. The shares were bought at an average price of $36.00 per share, with a total value of $360,000.00. Following the completion of the acquisition, the director now directly owns 165,000 shares of the company’s stock, valued at $5,940,000. The transaction was disclosed in a document filed with the SEC, which is available through this link.
Hedge Funds Weigh In On Astera Labs
An institutional investor recently bought a new position in Astera Labs stock. Allspring Global Investments Holdings LLC acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 251,596 shares of the company’s stock, valued at approximately $18,666,000. Allspring Global Investments Holdings LLC owned about 0.16% of Astera Labs at the end of the most recent reporting period.
Astera Labs Company Profile
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Articles
- Five stocks we like better than Astera Labs
- The 3 Best Fintech Stocks to Buy Now
- Comprehensive PepsiCo Stock Analysis
- Consumer Discretionary Stocks Explained
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- What Are Trending Stocks? Trending Stocks Explained
- Bear Market Funds to Watch This Year
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.